{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-26-000034","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2026-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.932875+00:00","generated_at":"2026-05-14T23:46:50.926683+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Integra LifeSciences Appoints Stuart Essig as President and CEO, Replacing Mojdeh Poul","bullets":["Stuart Essig appointed President and CEO effective May 1, 2026; he also remains Chairman of the Board.","Mojdeh Poul departed as President and CEO and from the Board effective April 30, 2026; she receives $566,526 lump sum.","Essig receives $1,075,000 base salary, 125% target bonus, and initial equity awards totaling $8 million in RSUs and options.","Michael McBreen appointed Chief Commercial Officer with base salary $660,000 and $1,000,000 one-time equity award.","Essig previously served as Integra's CEO from 1997 to 2012 and as Executive Chairman from February 2024 to June 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-26-000034","json":"https://secwatch.observer/filing/0000917520-26-000034.json","markdown":"https://secwatch.observer/filing/0000917520-26-000034.md","text":"https://secwatch.observer/filing/0000917520-26-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752026000034/0000917520-26-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752026000034/iart-20260430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-14T23:46:50.926683+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6a8ec94996","claim":"Stuart M. Essig was appointed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.","evidence_excerpt":"On May 5, 2026, Integra LifeSciences Holdings Corporation (the \"Company\") announced the appointment of Dr. Stuart M. Essig to serve as its President and Chief Executive Officer, effective as of May 1, 2026 (the \"Start Date\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752026000034/0000917520-26-000034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}]},{"claim_id":"72ce8b8151","claim":"Mojdeh Poul departed as Director at INTEGRA LIFESCIENCES HOLDINGS CORP.","evidence_excerpt":"Dr. Essig succeeds Mojdeh Poul, who is departing from her role as the Company's President and Chief Executive Officer and as a member of the Company's Board of Directors (the \"Board\") effective as of the end of the day on April 30, 2026 (the \"Separation Date\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752026000034/0000917520-26-000034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Director"}]},{"claim_id":"8d9f0cfff4","claim":"Mojdeh Poul departed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.","evidence_excerpt":"Dr. Essig succeeds Mojdeh Poul, who is departing from her role as the Company's President and Chief Executive Officer and as a member of the Company's Board of Directors (the \"Board\") effective as of the end of the day on April 30, 2026 (the \"Separation Date\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752026000034/0000917520-26-000034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"President and Chief Executive Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}